GRIA4 antibody
Quick Overview for GRIA4 antibody (ABIN6262083)
Target
See all GRIA4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- GRIA4 Antibody detects endogenous levels of total GRIA4
-
Cross-Reactivity
- Human, Mouse (Murine), Rat (Rattus)
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogen
- A synthesized peptide derived from human GRIA4
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:1000-3000, IF/ICC 1:100-1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C.Stable for 12 months from date of receipt
-
Expiry Date
- 12 months
-
-
- GRIA4 (Glutamate Receptor, Ionotropic, AMPA 4 (GRIA4))
-
Alternative Name
- GRIA4
-
Background
-
Description: Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.
Gene: GRIA4
-
Molecular Weight
- 120 kDa
-
Gene ID
- 2893
-
UniProt
- P48058
-
Pathways
- PI3K-Akt Signaling
Target
-